Literature DB >> 21327732

Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism.

Ivey N Rothman1, Laura Middleton, Brendan C Stack, Twyla Bartel, Ann T Riggs, Donald L Bodenner.   

Abstract

Positron emission tomography (PET) positive lesions are common in the thyroid. The uptake can be focal or diffuse. Diffuse thyroid uptake is thought to be indicative of autoimmune thyroiditis and not for lesions of malignant potential. Hashimoto's thyroiditis as a cause for diffusely positive thyroid glands has been demonstrated. We determine the incidence of diffuse thyroid PET positivity in hypothyroid patients, presumed to have Hashimoto's thyroiditis. The study design was retrospective database and electronic medical record review. The study setting includes tertiary care and academic health sciences center. The subjects were patients at our medical center who underwent positron emission tomography. Hypothyroid patients were identified who had total body PET imaging performed for any reason. Patients were excluded if they were not taking levothyroxine, had a history of neck surgery, neck irradiation, Graves' disease, taking lithium, thalidomide, amiodarone or interleukin. Patients remaining after the application of these exclusion criteria were presumed to be hypothyroid from Hashimoto's thyroiditis. Only 9.5% of PET scans of hypothyroid patients display diffuse thyroid activity. Only a small minority of presumed Hashimoto's thyroiditis patients will display diffuse thyroid activity after PET imaging. The etiology of this effect is unknown. Diffuse thyroid activity rarely requires surgical intervention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21327732     DOI: 10.1007/s00405-011-1512-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  11 in total

1.  Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.

Authors:  Ashraf Z Badros; Eric Siegel; Donald Bodenner; Maurizio Zangari; Jerome Zeldis; Bart Barlogie; Guido Tricot
Journal:  Am J Med       Date:  2002-04-01       Impact factor: 4.965

2.  The prevention of simple goiter in man. Second paper. 1918.

Authors:  O P Kimball; D Marine
Journal:  Nutrition       Date:  1992 May-Jun       Impact factor: 4.008

3.  Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects.

Authors:  Yen-Kung Chen; Hueisch-Jy Ding; Kuan-Tien Chen; Yen-Ling Chen; Alfred C Liao; Yeh-You Shen; Chen-Tau Su; Chia-Hung Kao
Journal:  Anticancer Res       Date:  2005 Mar-Apr       Impact factor: 2.480

4.  Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography.

Authors:  S C S Low; A K Sinha; F X Sundram
Journal:  Singapore Med J       Date:  2005-06       Impact factor: 1.858

5.  Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy.

Authors:  B O Helal; P Merlet; M E Toubert; B Franc; C Schvartz; H Gauthier-Koelesnikov; A Prigent; A Syrota
Journal:  J Nucl Med       Date:  2001-10       Impact factor: 10.057

6.  Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma.

Authors:  Annick Van den Bruel; Alex Maes; Tom De Potter; Luc Mortelmans; Maria Drijkoningen; Bo Van Damme; Pierre Delaere; Roger Bouillon
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

7.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas.

Authors:  Deanne L King; Brendan C Stack; Paul M Spring; Ronald Walker; Donald L Bodenner
Journal:  Otolaryngol Head Neck Surg       Date:  2007-09       Impact factor: 3.497

9.  Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.

Authors:  Seiji Kurata; Masatoshi Ishibashi; Yuji Hiromatsu; Hayato Kaida; Ikuyo Miyake; Masafumi Uchida; Naofumi Hayabuchi
Journal:  Ann Nucl Med       Date:  2007-08-27       Impact factor: 2.668

10.  Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.

Authors:  Dimitrios Karantanis; Trond V Bogsrud; Gregory A Wiseman; Brian P Mullan; Rathan M Subramaniam; Mark A Nathan; Patrick J Peller; Rebecca S Bahn; Val J Lowe
Journal:  J Nucl Med       Date:  2007-05-15       Impact factor: 10.057

View more
  6 in total

1.  Re: Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact.

Authors:  Brendan C Stack; Donald L Bodenner; Twyla B Bartel; Jacob Boeckmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07       Impact factor: 2.503

Review 2.  The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview.

Authors:  Giorgio Treglia; Barbara Muoio; Luca Giovanella; Massimo Salvatori
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-02       Impact factor: 2.503

3.  Breast and thyroid cancer: A multicenter study with Accrual to Clinical Trials Network.

Authors:  Merry Peckham; Horace J Spencer; Shorabuddin Syed; William B Armstrong; Donald Gregory Farwell; Thomas J Gal; David Goldenberg; Marika D Russell; Roberto N Solis; Deanne King; Brendan C Stack
Journal:  J Surg Oncol       Date:  2022-02-23       Impact factor: 2.885

4.  Diffuse thyroid uptake incidentally found on 18F-fluorodeoxyglucose positron emission tomography in subjects without cancer history.

Authors:  Ji Young Lee; Joon Young Choi; Yoon-Ho Choi; Seung Hyup Hyun; Seung Hwan Moon; Su Jin Jang; Yearn Seong Choe; Kyung-Han Lee; Byung-Tae Kim
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

Review 5.  The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases.

Authors:  Andor W J M Glaudemans; Erik F J de Vries; Filippo Galli; Rudi A J O Dierckx; Riemer H J A Slart; Alberto Signore
Journal:  Clin Dev Immunol       Date:  2013-08-21

6.  Bilateral diffuse fluorodeoxyglucose uptake in thyroid gland diagnosed by fluorodeoxyglucose-positron emission tomography/computed tomography.

Authors:  Aung Zaw Win; Carina Mari Aparici
Journal:  World J Nucl Med       Date:  2014-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.